{
  "pmcid": "7399295",
  "sha256": "63fde364f16d4f39b1a883391c28f05a8b63822e861e163c2e5181a93e437954",
  "timestamp_utc": "2025-11-09T22:54:54.247015+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.88499738493724,
    "reading_ease": 22.119462604602518,
    "word_count": 239
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "The EMPATHY Study: A Randomised Controlled Trial"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were randomly assigned in a 1:1 ratio"
      },
      "Participants": {
        "score": 2,
        "evidence": "enrolled patients with elevated low-density lipoprotein cholesterol (LDL-C) and diabetic retinopathy"
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomly assigned in a 1:1 ratio to receive intensive or standard statin therapy"
      },
      "Objective": {
        "score": 1,
        "evidence": "The EMPATHY study evaluates whether intensive statin therapy is superior to standard therapy in reducing cardiovascular events"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was a composite of CVD incidence and CVD-related death over a maximum follow-up of 5.5 years"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, with allocation concealment ensured"
      },
      "Blinding": {
        "score": 1,
        "evidence": "Blinding was applied to outcome assessors"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 5,144 patients were randomised (2,571 to intensive therapy and 2,573 to standard therapy)"
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Baseline data were analysed for 5,107 patients (2,550 in intensive and 2,557 in standard therapy) using an intention-to-treat approach"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The effect size and precision of the primary outcome are reported"
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were monitored, with no significant differences reported between groups"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: UMIN000003486"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding sources are disclosed in the full manuscript"
      }
    },
    "total_score": 21,
    "max_score": 25
  }
}